1. Beneluxa. Collaboration 2018 [15-2-2019].
http://www.beneluxa.org/collaboration
. Accessed 15 Feb 2019.
2. Beneluxa. The Beneluxa initiative on pharmaceutical policy—terms of reference 2018.
http://www.beneluxa.org/sites/beneluxa.org/files/2018-10/180622%20Terms%20of%20Reference%20Beneluxa%20Initiative.pdf
. Accessed 15 Feb 2019.
3. Department of Health. Minister Harris signs international agreement aimed at securing affordable and timely access to new medicines for Irish patients: ‘Department of Health; 2018.
https://health.gov.ie/blog/press-release/minister-harris-signs-international-agreement-aimed-at-securing-affordable-and-timely-access-to-new-medicines-for-irish-patients/
. Accessed 15 Feb 2019.
4. HIQA. Guidelines for the Economic Evaluation of Health Technologies in Ireland: Health Information and Quality Authority; 2018.
https://www.hiqa.ie/sites/default/files/2018-01/HIQA_Economic_Guidelines_2018.pdf
. Accessed 15 Feb 2019.
5. IPF. Guidelines on Health Economic Evaluation: Consensus Paper: Institut für Pharmaökonomische Forschung; 2006.
http://www.ipf-ac.at/fileadmin/template/PDF%20alt/Konsens_Guidelines_en.pdf
. Accessed 15 Feb 2019.